ASCO 2023
-
Poumon, cerveau, sein : des nouvelles avancées notables dans la lutte contre le cancer
CHICAGO 06/06 Rendez-vous phare des chercheurs et médecins oncologues du monde entier, le congrès annuel de l'American Society of Clinical Oncology (Asco) s'achève mardi à Chicago après avoir mis en lumière plusieurs avancées notables dans le traitement de la maladie.
Inscrivez-vous gratuitement
Afin d'accéder à l'info médicale nationale et internationale sur tous vos écrans.
ASCO 2023 : des études qui vont faire bouger les lignes
Cancer du poumon avancé : prévenir les thromboses pour éviter l'arrêt des traitements innovants
It's Okay to Say 'No': Setting Boundaries in Oncology
Oncologists need to learn how to set boundaries in their professional lives and how to address their fear of saying '...
Less Therapy May Suit Older Patients With Breast Cancer
By definition, all clinical care is — or should be — patient-centered care, and that is especially true for older wom...
Cancer Vaccines Poised to Unlock 'New Treatment Paradigm' With Merck/Moderna Data
Adding an experimental mRNA-based vaccine from Moderna Inc and Merck & Co reduced the risk that the most deadly skin ...
Meta-Analysis Supports Ovarian Suppression in Breast Cancer
A new meta-analysis of 25 studies dating back to 1948 provides more evidence linking ovarian suppression/ablation in ...
Huge Underuse of Germline Testing for Cancer Patients
Fewer than 7% of patients newly diagnosed with cancer are tested for germline genetic mutations, and the percentage t...
Oral Drug for Brain Tumor Could Change Treatment Landscape
Patients with a certain type of brain tumor could soon be treated with an oral targeted drug instead of undergoing mo...
Safe to Stop Immunotherapy at 2 Years in Stable Lung Cancer
Immune checkpoint inhibitors are a cornerstone of non–small cell lung cancer treatment. But there is a question that’...
Le vorasidenib donne de bons résultats dans les gliomes de bas grade mutants pour IDH